Fuso Pharmaceutical Industries,Ltd. (4538.T)
JPY 2585.0
(0.35%)
JPY 2585.0
(0.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 627 Million | 2.85 Billion | 3.49 Billion | 3.23 Billion | 5.72 Billion | 2.05 Billion |
| Net Income | 1.37 Billion | 2.2 Billion | 1.91 Billion | 2.34 Billion | 1.04 Billion | 1.25 Billion |
| Depreciation & Amortization | 1.73 Billion | 2.48 Billion | 2.55 Billion | 2.41 Billion | 2.38 Billion | 1.96 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.92 Billion | -1.08 Billion | 1.09 Billion | -1.5 Billion | 2.43 Billion | -494 Million |
| Other non-cash items | 6.49 Billion | -752 Million | -2.06 Billion | -23 Million | -129 Million | -677 Million |
| Investing Cash Flow | -3.53 Billion | -1.37 Billion | -1.55 Billion | -978 Million | -1.48 Billion | -2.36 Billion |
| Investments in PPE | -3.58 Billion | -1.57 Billion | -1.48 Billion | -1.21 Billion | -2.5 Billion | -2.31 Billion |
| Acquisitions | - | - | -1 Million | 130 Million | -2 Million | -1 Million |
| Investment purchases | - | - | -47 Million | -130 Million | 177 Million | -70 Million |
| Sales/Maturities of investments | 84 Million | 242 Million | 29 Million | 40 Million | 974 Million | 73 Million |
| Other Investing Activities | -32 Million | -41 Million | -47 Million | 192 Million | -132 Million | -53 Million |
| Financing Cash Flow | 14 Million | -813 Million | -1.67 Billion | -2.44 Billion | -1.79 Billion | -313 Million |
| Debt repayment | -1.31 Billion | -3.81 Billion | -4.03 Billion | -4.31 Billion | -4.37 Billion | -3.9 Billion |
| Dividends payments | -645 Million | -525 Million | -525 Million | -525 Million | -613 Million | -700 Million |
| Common Stock Repurchased | -652 Million | -3 Million | -2 Million | -4 Million | -2 Million | -6 Million |
| Common Stock Issuance | - | 3.53 Billion | 2.88 Billion | 2.39 Billion | 3.18 Billion | 4.31 Billion |
| Other Financing Activities | -2 Million | -1 Million | -1 Million | -1 Million | -2 Million | -15 Million |
| Accounts receivables | -2.58 Billion | -588 Million | 231 Million | -983 Million | 1.66 Billion | -84 Million |
| Accounts payables | 1.74 Billion | 1.45 Billion | 715 Million | -325 Million | 634 Million | 416 Million |
| Inventory | -1.75 Billion | -1.94 Billion | 213 Million | -712 Million | 280 Million | -654 Million |
| Other working capital | -333 Million | -10 Million | -65 Million | 518 Million | -143 Million | -172 Million |
| Cash at beginning of period | 8.01 Billion | 7.34 Billion | 7.07 Billion | 7.26 Billion | 4.82 Billion | 5.45 Billion |
| Cash at end of period | 5.12 Billion | 8.01 Billion | 7.34 Billion | 7.07 Billion | 7.26 Billion | 4.82 Billion |
| Capital Expenditure | -3.58 Billion | -1.57 Billion | -1.48 Billion | -1.21 Billion | -2.5 Billion | -2.31 Billion |
| Effect of forex changes on cash | - | - | -1 Million | - | - | - |
| Net cash flow / Change in cash | -2.89 Billion | 667 Million | 273 Million | -194 Million | 2.44 Billion | -631 Million |
| Free Cash Flow | -2.96 Billion | 1.27 Billion | 2.01 Billion | 2.02 Billion | 3.22 Billion | -267 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.37 Billion | 510 Million | 238 Million | 479 Million | 2.2 Billion | 112 Million |
| Depreciation & Amortization | 1.73 Billion | 559 Million | 541 Million | 539 Million | 2.48 Billion | 545 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.92 Billion | - | - | - | -1.08 Billion | - |
| Other non-cash items | 6.49 Billion | 49 Million | 303 Million | 60 Million | -752 Million | 433 Million |
| Investing Cash Flow | -3.53 Billion | - | - | - | -1.37 Billion | - |
| Investments in PPE | -3.58 Billion | - | - | - | -1.57 Billion | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 84 Million | - | - | - | 242 Million | - |
| Other Investing Activities | -32 Million | - | - | - | -41 Million | - |
| Financing Cash Flow | 14 Million | - | - | - | -813 Million | - |
| Debt repayment | -1.31 Billion | - | - | - | -3.81 Billion | - |
| Dividends payments | -645 Million | - | - | - | -525 Million | - |
| Common Stock Repurchased | -652 Million | - | - | - | -3 Million | - |
| Common Stock Issuance | - | - | - | - | 3.53 Billion | - |
| Other Financing Activities | -2 Million | - | - | - | -1 Million | - |
| Accounts receivables | -2.58 Billion | - | - | - | -588 Million | - |
| Accounts payables | 1.74 Billion | - | - | - | 1.45 Billion | - |
| Inventory | -1.75 Billion | - | - | - | -1.94 Billion | - |
| Other working capital | -333 Million | - | - | - | -10 Million | - |
| Cash at beginning of period | 8.01 Billion | 7.52 Billion | 8.08 Billion | 8.01 Billion | 7.34 Billion | 8.14 Billion |
| Cash at end of period | 5.12 Billion | 6.67 Billion | 7.52 Billion | 8.08 Billion | 8.01 Billion | 8.01 Billion |
| Capital Expenditure | -3.58 Billion | - | - | - | -1.57 Billion | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.89 Billion | -844 Million | -559 Million | 67 Million | 667 Million | -134 Million |
| Free Cash Flow | -2.96 Billion | 1.11 Billion | 1.08 Billion | 1.07 Billion | 1.27 Billion | 1.09 Billion |
CDBDF
UPPR
TANA
MPZZF
000760
300636